Clinical trial
Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
NCT06772220 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
- Lead sponsor
- Oregon Health and Science University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 5, 2024
- Completion date
- December 31, 2025
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease